Yefu Liu
Overview
Explore the profile of Yefu Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Li W, Sun S, Liu Y
Front Cell Dev Biol
. 2024 Nov;
12:1494631.
PMID: 39605984
Fibrillarin (FBL) is a highly conserved and well-researched nucleolar protein found in eukaryotes. Its presence was first identified in 1985 through protein immunoblotting analyses using antisera from patients with autoimmune...
2.
Jin Z, Guo T, Zhang X, Wang X, Liu Y
Front Oncol
. 2024 Oct;
14:1448695.
PMID: 39474113
Protein tyrosine kinase 7 (PTK7) is an evolutionarily conserved transmembrane receptor and a specialized tyrosine kinase protein lacking kinase activity. PTK7 has been found to be strongly associated with a...
3.
Jin Z, Wang X, Zhang X, Cheng S, Liu Y
Front Genet
. 2024 Sep;
15:1441189.
PMID: 39323867
Background: High heterogeneity is an essential feature of malignant tumors. This study aims to reveal the drivers of hepatocellular carcinoma heterogeneity for prognostic stratification and to guide individualized treatment. Methods:...
4.
Huang J, Gao G, Ge Y, Liu J, Cui H, Zheng R, et al.
Dig Dis Sci
. 2024 Mar;
69(4):1263-1273.
PMID: 38451429
Background: A grim prognosis of pancreatic cancer (PCa) was attributed to the difficulty in early diagnosis of the disease. Aims: Identifying novel biomarkers for early detection of PCa is thus...
5.
Tian Q, Wang H, Guo T, Yao B, Liu Y, Zhu B
Ann Med
. 2024 Jan;
56(1):2306194.
PMID: 38279689
Background: Although ERAS Program had some advantages in laparoscopic distal gastrectomy (LDG), its efficacy and safety remained unclear. We conducted a systematic review and meta-analysis to assess the efficacy and...
6.
Chang Y, Guo T, Zhu B, Liu Y
Ann Hepatol
. 2023 Jul;
28(6):101136.
PMID: 37479060
Introduction And Objectives: In hepatocellular carcinoma (HCC), the prognosis of patients with microvascular invasion (MVI) is poor. Therefore, in this study, we established and evaluated the performance of a novel...
7.
Zhu B, Wu X, An W, Yao B, Liu Y
Front Public Health
. 2022 Sep;
10:908955.
PMID: 36148350
Background: There is a lack of in-depth analysis regarding the disease burden of childhood cancer in China. Indeed, this is the first time the topic has been addressed in detail....
8.
Guo T, Wang Z, Liu Y
J Gastrointest Oncol
. 2021 Nov;
12(5):2172-2191.
PMID: 34790383
Background: Gastrointestinal malignant cancers affect many sites in the intestinal tract, including the colon. In this study, we purposed to improve prognostic predictions for colon cancer (CC) patients by establishing...
9.
Zhu B, Wu X, Guo T, Guan N, Liu Y
Cancer Control
. 2021 Oct;
28:10732748211051536.
PMID: 34713730
Background: Pancreatic cancer is an aggressive cancer and is predicted to become the second leading cause of cancer-related deaths in China. To understand the epidemic trend of pancreatic cancer and...
10.
Lv C, Wang S, Lin L, Wang C, Zeng K, Meng Y, et al.
Cell Death Dis
. 2021 Aug;
12(9):803.
PMID: 34420039
Hepatocellular carcinoma (HCC) is the most common visceral neoplasms with its heterogeneity and high rate of recurrence. HCC is characterized to be delayed diagnosis and the development of resistant disease....